140 related articles for article (PubMed ID: 9815205)
1. Etiology of measles- and rubella-like illnesses in measles, mumps, and rubella-vaccinated children.
Davidkin I; Valle M; Peltola H; Hovi T; Paunio M; Roivainen M; Linnavuori K; Jokinen S; Leinikki P
J Infect Dis; 1998 Dec; 178(6):1567-70. PubMed ID: 9815205
[TBL] [Abstract][Full Text] [Related]
2. Etiology of mumps-like illnesses in children and adolescents vaccinated for measles, mumps, and rubella.
Davidkin I; Jokinen S; Paananen A; Leinikki P; Peltola H
J Infect Dis; 2005 Mar; 191(5):719-23. PubMed ID: 15688285
[TBL] [Abstract][Full Text] [Related]
3. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
Zäch K; Nicoara C; Germann D; Matter L
Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
[TBL] [Abstract][Full Text] [Related]
4. [Immunity to measles, mumps and rubella in children vaccinated with triple viral vaccine].
Pisón Garcés FJ; Galbe Sánchez-Ventura J; Arcauz Eguren P; Aguirre y Dabán C; Mengual Gil J; Larrad Mur L
Aten Primaria; 1995 Mar; 15(4):235-7. PubMed ID: 7703334
[TBL] [Abstract][Full Text] [Related]
5. Similar Antibody Levels in 3-Year-Old Children Vaccinated Against Measles, Mumps, and Rubella at the Age of 12 Months or 18 Months.
Kontio M; Palmu AA; Syrjänen RK; Lahdenkari M; Ruokokoski E; Davidkin I; Vaarala O; Melin M
J Infect Dis; 2016 Jun; 213(12):2005-13. PubMed ID: 26908733
[TBL] [Abstract][Full Text] [Related]
6. Decline in rates of seropositivity for measles, mumps, and rubella antibodies among previously immunized children treated for acute leukemia.
Feldman S; Andrew M; Norris M; McIntyre B; Iyer R
Clin Infect Dis; 1998 Aug; 27(2):388-90. PubMed ID: 9709893
[TBL] [Abstract][Full Text] [Related]
7. Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection.
Dennehy PH; Saracen CL; Peter G
Pediatrics; 1994 Oct; 94(4 Pt 1):514-6. PubMed ID: 7936862
[TBL] [Abstract][Full Text] [Related]
8. Etiology of measles suspect cases reported in 2006-2007 in Poland.
Siennicka J; Stefanoff P; Rogalska J; Trzcińska A
Przegl Epidemiol; 2011; 65(1):39-44. PubMed ID: 21735834
[TBL] [Abstract][Full Text] [Related]
9. Rash after measles vaccination: laboratory analysis of cases reported in São Paulo, Brazil.
Oliveira MI; Curti SP; Figueiredo CA; Afonso AM; Theobaldo M; Azevedo RS; Durigon EL
Rev Saude Publica; 2002 Apr; 36(2):155-9. PubMed ID: 12045795
[TBL] [Abstract][Full Text] [Related]
10. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
[TBL] [Abstract][Full Text] [Related]
11. Antibody response to measles-mumps-rubella vaccine of children with mild illness at the time of vaccination.
King GE; Markowitz LE; Heath J; Redd SC; Coleman S; Bellini WJ; Sievert A
JAMA; 1996 Mar; 275(9):704-7. PubMed ID: 8594268
[TBL] [Abstract][Full Text] [Related]
12. Decline of mumps antibodies in type 1 (insulin-dependent) diabetic children and a plateau in the rising incidence of type 1 diabetes after introduction of the mumps-measles-rubella vaccine in Finland. Childhood Diabetes in Finland Study Group.
Hyöty H; Hiltunen M; Reunanen A; Leinikki P; Vesikari T; Lounamaa R; Tuomilehto J; Akerblom HK
Diabetologia; 1993 Dec; 36(12):1303-8. PubMed ID: 8307260
[TBL] [Abstract][Full Text] [Related]
13. Differential diagnosis of fever and rash cases negative for measles and rubella to complement surveillance activities.
Fappani C; Gori M; Bianchi S; Terraneo M; Bilardi E; Colzani D; Tanzi E; Canuti M; Amendola A
J Med Virol; 2023 Oct; 95(10):e29141. PubMed ID: 37796084
[TBL] [Abstract][Full Text] [Related]
14. Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients.
King SM; Saunders EF; Petric M; Gold R
Bone Marrow Transplant; 1996 Apr; 17(4):633-6. PubMed ID: 8722367
[TBL] [Abstract][Full Text] [Related]
15. Serological evaluation of 52 children immunized with the combined measles, mumps and rubella vaccine.
Topal B; Kanra G; Ceyhan M
Turk J Pediatr; 1991; 33(1):13-8. PubMed ID: 1844171
[TBL] [Abstract][Full Text] [Related]
16. Role of human herpesvirus 6 infection in young Brazilian children with rash illnesses.
Vianna RA; de Oliveira SA; Camacho LA; Knowles W; Brown D; Pereira AC; Velarde LG; Siqueira MM
Pediatr Infect Dis J; 2008 Jun; 27(6):533-7. PubMed ID: 18449066
[TBL] [Abstract][Full Text] [Related]
17. Measles, mumps, rubella antibody surveillance: pilot study in Grampian, Scotland.
Narayan KM; Moffat MA
Health Bull (Edinb); 1992 Jan; 50(1):47-53. PubMed ID: 1612895
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of IgG-antibodies to mumps and measles virus in non-vaccinated children.
Glikmann G; Petersen I; Mordhorst CH
Dan Med Bull; 1988 Apr; 35(2):185-7. PubMed ID: 3359817
[TBL] [Abstract][Full Text] [Related]
19. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
Stohrer-Draxl P; Amstad H; Grize L; Gassner M; Takken-Sahli K; Bourquin C; Braun-Fahrländer C
Praxis (Bern 1994); 1999 Jun; 88(24):1069-77. PubMed ID: 10420798
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and genotypic characterization of Human Parvovirus B19 in children with measles- and rubella-like illness in Iran.
Rezaei F; Sarshari B; Ghavami N; Meysami P; Shadab A; Salimi H; Mokhtari-Azad T
J Med Virol; 2016 Jun; 88(6):947-53. PubMed ID: 26538067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
